Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Dec;8(10):1143-1144.
doi: 10.1177/2050640620965113. Epub 2020 Oct 12.

Paving the way towards a weight-loss intervention study in obese patients with inflammatory bowel disease

Julien Kirchgesner  1
Affiliations
Editorial

Paving the way towards a weight-loss intervention study in obese patients with inflammatory bowel disease

Julien Kirchgesner. United European Gastroenterol J. 2020 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Singh S, Dulai PS, Zarrinpar A, et al. Obesity in IBD: Epidemiology, pathogenesis, disease course and treatment outcomes. Nature Rev Gastroenterol Hepatol 2017; 14: 110–121. - PMC - PubMed
    1. Greuter T. Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss IBD cohort. United European Gastroenterol J 2020. - PMC - PubMed
    1. Kant P, Fazakerley R, Hull MA. Faecal calprotectin levels before and after weight loss in obese and overweight subjects. Int J Obesity 2013; 37: 317–319. - PubMed
    1. Jain A, Nguyen NH, Proudfoot JA, et al. Impact of obesity on disease activity and Patient-Reported Outcomes Measurement Information System (PROMIS) in inflammatory bowel diseases . Am J Gastroenterol 2019; 114: 630–639. - PMC - PubMed
    1. Lupoli R, Pizzicato P, Scalera A, et al. Impact of body weight on the achievement of minimal disease activity in patients with rheumatic diseases: A systematic review and meta-analysis. Arthritis Res Ther 2016; 18: 297. - PMC - PubMed